Dr Kun Wang | Biomaterials | Best Researcher Award

Posted on by sciencefather

Dr Kun Wang | Biomaterials | Best Researcher Award

Dr. Kun Wang is a renowned medical expert 👨‍⚕️ specializing in burn and wound repair 🔥🩹. He serves as Director at Weifang People’s Hospital and is a Chief Physician and Master’s Supervisor at Shandong Second Medical University 🎓. With expertise in treating complex burns, chronic wounds, and scars, he pioneers advanced treatments like laser therapy and minimally invasive surgery 💡🔬. Dr. Wang leads key research labs on tissue regeneration and has earned prestigious honors including the “Outstanding Physician of Shandong Province” 🏅. His dedication to medical innovation and education makes him a leading figure in clinical research and patient care in China 🇨🇳.

Dr Kun Wang, Weifang People’s Hospital, China

Profile

SCOPUS

Academic Leader 🎓

Dr. Kun Wang is a distinguished academic leader 🎓 in the field of burn and plastic surgery 🔥🧬. He heads the Key Medical Discipline of Shandong Province and Weifang City 🏥, and directs the Weifang Key Laboratory of Traditional Chinese Medicine for Sore Repair and Tissue Regeneration 🌿🔬. His contributions to clinical education and research have earned him top honors, including the 2023 “Outstanding Physician of Shandong Province” and the “Weiwei Craftsman” award 🏅. Through his leadership, he fosters innovation, mentors young professionals, and elevates standards in medical education and research across China 🇨🇳.

Experience 🩺

Dr. Kun Wang brings extensive clinical and academic experience 🩺📘 to the field of burn and wound care. As Director of the Department of Burns and Wound Repair at Weifang People’s Hospital and Chief Physician 👨‍⚕️, he leads innovations in burn treatment, chronic wound healing, and scar management 🔥🧪. He also mentors future medical professionals as a Master’s Supervisor 🎓 and heads the Burn Surgery Discipline Group at Shandong Second Medical University. Recognized for his excellence, he was awarded the 2023 “Outstanding Physician of Shandong Province” and “Weiwei Craftsman” honors 🏅, showcasing his leadership, dedication, and impact in healthcare innovation 🌟.

Clinical Expert 👨‍⚕️

Dr. Kun Wang is a seasoned clinical expert 👨‍⚕️ in advanced burn and wound care, specializing in treating complex cases such as deep burns, pediatric and geriatric burns, as well as chemical and electrical injuries 🔥🧒👵⚡. He excels in scar management through minimally invasive surgery, laser therapy, physical therapy, and medications 💉🔬. His expertise also extends to chronic wound healing, including diabetic foot, pressure ulcers, and non-healing surgical wounds 🦶🩹. Additionally, Dr. Wang is proficient in surgical treatments for superficial tumors and scar carcinoma, performing skin grafts and flap reconstructions with precision and care 🧫🔧.

Professional Affiliations 🏥

Dr. Kun Wang holds esteemed positions across numerous national and regional medical associations, showcasing his influential role in burn and wound care research and practice 🩺🌐. He is a committee member in key organizations such as the Chinese Medical Association, Chinese Association of Integrative Medicine, and the Chinese Association of Plastic and Aesthetics 🇨🇳🧬. Regionally, he serves as Vice Chairman and Chairman in multiple Shandong and Weifang medical societies, including those focused on tissue regeneration, plastic surgery, and disaster medicine 🧑‍⚕️🧪. His professional affiliations reflect his dedication to advancing collaborative, interdisciplinary healthcare and research nationwide 🤝🏥.

Research Focus 🔬

Dr. Kun Wang’s research focus centers on advanced wound healing technologies, particularly in diabetic patients 🧫🩹. His work highlights the development of multifunctional dressings, such as those incorporating curcumin, which demonstrate powerful anti-inflammatory, antioxidant, angiogenic, and collagen-regenerating properties 🌿🧪. These innovations aim to enhance tissue repair, accelerate healing, and reduce complications in chronic wounds like diabetic ulcers 🦶🔥. By merging traditional Chinese medicine with modern biomedical science, Dr. Wang contributes significantly to improving patient outcomes in burn and wound care 🔬❤️‍🩹. His research plays a vital role in next-generation therapies for complex and non-healing wounds.

Publication 📄

Paper Title: Multi-functional dressing with curcumin displays anti-inflammatory, antioxidant, angiogenic, and collagen regeneration effects in diabetic wound healing
Authors: Dr. Kun Wang, et al.
Journal: Journal of Wound Care

Dr Binod Dhakal | Biomaterials | Best Researcher Award

Posted on by sciencefather

Dr Binod Dhakal | Biomaterials | Best Researcher Award

Dr. Binod Dhakal is an esteemed hematologist-oncologist 🩸🎗️ and Associate Professor at the Medical College of Wisconsin 🏥. He holds an M.D. from Saint Francis Hospital and an MBBS from Manipal College of Medical Sciences, with an M.S. in Clinical & Translational Science. His research focuses on multiple myeloma, CAR-T cell therapy, and cancer immunotherapy 🧬. Dr. Dhakal has secured multimillion-dollar grants 💰, received prestigious awards 🏅, and serves as a reviewer for leading oncology journals 📖. His contributions to oncology research and education make him a top contender for the Best Researcher Award.

Dr Binod Dhakal, Medical College of Wisconsin, United States

Profile

GOOGLESCHOLAR

SCOPUS

Education🎓

Dr. Binod Dhakal has an impressive academic journey in medicine and oncology 🏥🔬. He earned his MBBS from Manipal College of Medical Sciences, Nepal 🇳🇵 (1999-2004) and later completed his M.D. at Saint Francis Hospital, Evanston, IL, USA 🇺🇸 (2007-2010). He specialized further as a Hematology/Oncology Fellow at the Medical College of Wisconsin (2013-2016) 🩸🎗️. To strengthen his research expertise, he obtained an M.S. in Clinical & Translational Science from the Clinical and Translational Institute of Southeast Wisconsin (2015-2016) 📊🧬. His extensive education underscores his commitment to advancing cancer research and patient care.

Awards and Honors 🏆

Dr. Binod Dhakal is a highly acclaimed hematologist-oncologist 🎗️, recognized for his excellence in medical research and education 📚. He has received numerous prestigious awards, including the American Society of Oncology Travel Trainee Award ✈️, Best Oral Abstract Award 🏅, and Outstanding Medical Student Teacher Award 🏫. His leadership was further acknowledged as Chief Fellow in Hematology/Oncology 🏥. Dr. Dhakal’s groundbreaking work in multiple myeloma and cancer immunotherapy 🧬 has earned him esteemed fellowships and research accolades. His dedication to advancing oncology and mentoring future physicians makes him a leading figure in the field.

Contributions 👨‍🏫

Dr. Binod Dhakal is a dedicated mentor and faculty leader, guiding numerous fellows and researchers in multiple myeloma studies 🩸🧬. Since 2016, he has mentored Guru Subramaniam in research and MS thesis development. His mentorship extends to esteemed fellows like Smith Giri (2018-Present), Madan Aryal (2018-2022), Lindsay Hammons (2021-2023), and Ramsha Ahmed (2022-Present) 📚🔍. His contributions continue with Bicky Thapa, Gulrayz Ahmed, Ravi Narra, Jennifer Obasi, Othman Akhtar, Fumou Sun, and Kritika Yadav, ensuring future advancements in hematology and oncology. His commitment to training the next generation of experts solidifies his impact in medical research.

Books Chapters 📖

Dr. Binod Dhakal has made significant contributions to medical literature through books, chapters, and editorial works 📚📝. His 2011 piece, Medical Student Perspectives: Journey Through Different Worlds, explores user-driven healthcare. He co-authored statistical analysis discussions in Current Concepts and Controversies in Hematopoietic Cell Transplantation (2014) 📊📖. His works on allogeneic stem cell transplantation and CAR-T therapy in multiple myeloma (2015-2020) in Bone Marrow Transplantation and Blood Reviews provide crucial insights into hematology and oncology 🩸🧬. His expertise in narrative medicine, stem cell therapy, and cancer research continues to shape the field.

Research Focus 🔬

Dr. Binod Dhakal’s research primarily focuses on multiple myeloma, hematopoietic cell transplantation (HCT), and CAR-T cell therapy 🧬🧑‍⚕️. His work explores stem cell mobilization with novel induction therapies, B-cell maturation antigen (BCMA)-directed immunotherapy, and cytokine release syndrome in HCT patients 💉🦠. He has investigated the role of beta-blockers like propranolol in reducing molecular risk markers and examined the ethical challenges in CAR-T cell therapy slot allocation ⚖️🔍. His research provides groundbreaking insights into improving transplant success rates and reducing treatment-related complications, shaping the future of oncology and hematology. 🚀📚

Publications 📚

“Cilta-cel or standard care in lenalidomide-refractory multiple myeloma” 🧬💊
🖊 Authors: J. San-Miguel, B. Dhakal, K. Yong, A. Spencer, S. Anguille, M.V. Mateos, et al.
📖 Journal: New England Journal of Medicine 🏥
📅 Year: 2023
📊 Citations: 400

“Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma (OPTIMISMM): a randomised, open-label study” 💉🔬
🖊 Authors: P.G. Richardson, A. Oriol, M. Beksac, A.M. Liberati, M. Galli, F. Schjesvold, et al.
📖 Journal: The Lancet Oncology 🏥
📅 Year: 2019
📊 Citations: 400

“Daratumumab, carfilzomib, lenalidomide, and dexamethasone with minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma” 🦠🩸
🖊 Authors: L.J. Costa, S. Chhabra, E. Medvedova, B.R. Dholaria, T.M. Schmidt, K.N. Godby, et al.
📖 Journal: Journal of Clinical Oncology 🏥
📅 Year: 2022
📊 Citations: 220

“Autologous transplantation for newly diagnosed multiple myeloma in the era of novel agent induction: a systematic review and meta-analysis” 🏥📊
🖊 Authors: B. Dhakal, A. Szabo, S. Chhabra, M. Hamadani, A. D’Souza, S.Z. Usmani, et al.
📖 Journal: JAMA Oncology 🩺
📅 Year: 2018
📊 Citations: 187